HelixBind Competitors and Similar CompaniesClear all
HelixBind's competitors and similar companies include Bone Therapeutics, Adaptive Biotechnologies, Mobidiag and Rosa Biotech.
 HelixBind HelixBind is a company that develops a diagnostic platform to detect bloodstream infections. |  Bone Therapeutics Bone Therapeutics is a leading biotechnology company specializing in the development of cell therapy products intended for bone fracture repair and prevention. |  Adaptive Biotechnologies Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease. |  Mobidiag Mobidiag is a biotechnology company that provides solutions for in vitro diagnostics of infectious diseases. | ||
Founding Date | Founding Date 2013 | Founding Date 2006 | Founding Date 2009 | Founding Date 2000 | Founding Date 2019 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Boxborough, US HQ | Locations Charleroi, BE HQ Charleroi, BE | Locations Seattle, US HQ New York, US South San Francisco, US | Locations Espoo, FI HQ Paris, FR Vallentuna, SE Loudwater, GB | Locations Bristol, GB HQ |
Employees | Employees 31 | Employees 20 | Employees 70910% decrease | Employees 7312% decrease | Employees 3 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $179m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $72.1m (FY, 2024) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €545k (FY, 2023) | Gross profit $106.9m (FY, 2024) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income (€29m) (FY, 2023) | Net income ($159.6m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 1.7m (over 11 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 1.7m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.7m | Total funding raised $ 10.4m | Total funding raised $ 525m | Total funding raised $ 74m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Bone Therapeutics
HQ
Charleroi, BE
Employees
20
Bone Therapeutics is a leading biotechnology company specializing in the development of cell therapy products intended for bone fracture repair and prevention.
View companyAdaptive Biotechnologies
HQ
Seattle, US
Employees
709↓ 10% decrease
Adaptive Biotechnologies (formerly known as Adaptive TCR) is a company that develops diagnostics and therapeutic tools based on the immune response to disease.
View companyMobidiag
HQ
Espoo, FI
Employees
73↓ 12% decrease
Mobidiag is a biotechnology company that provides solutions for in vitro diagnostics of infectious diseases.
View company
Rosa Biotech
HQ
Bristol, GB
Employees
3
Rosa Biotech is an AI-driven biosensing and diagnostics company.
View company